Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 10779419)

1.

Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.

Schefler AC, Kleinerman RA, Abramson DH.

Expert Rev Ophthalmol. 2008 Feb 1;3(1):51-61.

2.

Modeling the risk of secondary malignancies after radiotherapy.

Schneider U.

Genes (Basel). 2011 Nov 29;2(4):1033-49. doi: 10.3390/genes2041033.

3.

Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

Berbis J, Michel G, Baruchel A, Bertrand Y, Chastagner P, Demeocq F, Kanold J, Leverger G, Plantaz D, Poirée M, Stephan JL, Auquier P, Contet A, Dalle JH, Ducassou S, Gandemer V, Lutz P, Sirvent N, Tabone MD, Thouvenin-Doulet S.

Int J Epidemiol. 2015 Feb;44(1):49-57. doi: 10.1093/ije/dyu031. Epub 2014 Mar 17.

PMID:
24639445
4.

Radiation associated tumors following therapeutic cranial radiation.

Chowdhary A, Spence AM, Sales L, Rostomily RC, Rockhill JK, Silbergeld DL.

Surg Neurol Int. 2012;3:48. doi: 10.4103/2152-7806.96068. Epub 2012 May 14.

5.

An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma.

Downing ME, Dite GS, Ballinger ML; International Sarcoma Kindred Study Consortium.

Clin Sarcoma Res. 2012 Jan 9;2(1):1. doi: 10.1186/2045-3329-2-1.

6.

Treatment-related myelodysplasia in patients with primary brain tumors.

Baehring JM, Marks PW.

Neuro Oncol. 2012 May;14(5):529-40. doi: 10.1093/neuonc/nos068. Epub 2012 Mar 29. Review.

7.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

8.

Radiation-induced glioblastoma multiforme in a remitted acute lymphocytic leukemia patient.

Joh D, Park BJ, Lim YJ.

J Korean Neurosurg Soc. 2011 Sep;50(3):235-9. doi: 10.3340/jkns.2011.50.3.235. Epub 2011 Sep 30.

9.

Epidemiology of therapy-related myeloid neoplasms after treatment for pediatric acute lymphoblastic leukemia in the nordic countries.

Schmiegelow K.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011020. doi: 10.4084/MJHID.2011.020. Epub 2011 May 16.

10.

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, Doolittle ND, Baehring J, Pradhan K, Martin SE, Guerrera M, Shah S, Ghesquieres H, Silver M, Betensky RA, Batchelor T.

Clin Cancer Res. 2011 Jan 15;17(2):346-52. doi: 10.1158/1078-0432.CCR-10-1161. Epub 2011 Jan 11.

11.

Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Brassesco MS, Xavier DJ, Camparoto ML, Montaldi AP, de Godoy PR, Scrideli CA, Tone LG, Sakamoto-Hojo ET.

J Biomed Biotechnol. 2011;2011. pii: 230481. doi: 10.1155/2011/230481. Epub 2010 Aug 31. Review.

12.

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP.

J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95. doi: 10.1093/jnci/djq238. Epub 2010 Jul 15.

13.

Secondary osteosarcoma arising after treatment for childhood hematologic malignancies.

Okada A, Hatori M, Hosaka M, Watanuki M, Itoi E.

Ups J Med Sci. 2009;114(4):249-55. doi: 10.3109/03009730903177340.

14.

Secondary malignancies across the age spectrum.

Ng AK, Kenney LB, Gilbert ES, Travis LB.

Semin Radiat Oncol. 2010 Jan;20(1):67-78. doi: 10.1016/j.semradonc.2009.09.002. Review.

15.

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, Heyman M, Kristinsson J, Nersting J, Nygaard R, Svendsen AL, Vettenranta K, Weinshilboum R; Nordic Society for Paediatric Haematology and Oncology.

Blood. 2009 Jun 11;113(24):6077-84. doi: 10.1182/blood-2008-11-187880. Epub 2009 Feb 17.

16.

Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.

Banerjee J, Pääkkö E, Harila M, Herva R, Tuominen J, Koivula A, Lanning M, Harila-Saari A.

Neuro Oncol. 2009 Oct;11(5):543-9. doi: 10.1215/15228517-2008-122. Epub 2009 Jan 29.

17.

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.

Verma D, O'Brien S, Thomas D, Faderl S, Koller C, Pierce S, Kebriaei P, Garcia-Manero G, Cortes J, Kantarjian H, Ravandi F.

Cancer. 2009 Jan 1;115(1):101-6. doi: 10.1002/cncr.24005.

18.

Childhood leukaemia: long-term excess mortality and the proportion 'cured'.

Shah A, Stiller CA, Kenward MG, Vincent T, Eden TO, Coleman MP.

Br J Cancer. 2008 Jul 8;99(1):219-23. doi: 10.1038/sj.bjc.6604466.

19.

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, Yasui Y, Robison LL, Neglia JP.

Blood. 2008 Jun 15;111(12):5515-23. doi: 10.1182/blood-2007-10-117150. Epub 2008 Mar 11.

20.

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers ME, Tichelli A, Sanders JE, Deeg HJ, Socie G; FHCRC; EBMT-Late Effect Working Party.

Blood. 2008 Jan 15;111(2):939-44. Epub 2007 Oct 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk